Pfizer AG - Dalacin C 300 mg, Hartkapseln | | 35438 | | 05 | | Dalacin C 300 mg | | Hartkapseln | | J01FF01 | | Clindamycin | | 22.08.2006 | | |
| Composition | clindamycinum 300 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 283.27 mg, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. | Packungsbestandteile | | Capsules | | | Principe actif | Concentr. |
---|
Clindamycine | 300 mg |
| BAG: Principe actif | Concentr. |
---|
Clindamycine | 300 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Nigrum) | | | Ammoniae Solutio Concentrata | | | E 171 | | color. | E 172 | | color. | Gelatina | | Kapselhülle | Kalii Hydroxidum | | | Lacca | | Drucktinte | Lactose Monohydrate | 283.27 mg | | Magnesii Stearas | | | Maydis Amylum | | | Pro Capsula | | | Propylenglycol | | | Talcum | | |
| |
| couper ou écraser | | | -- | | | | Ja | | | | -- | | | | Ja | | | | Bitterer Geschmack. Alternative: Dalacin C Granulat zur Herstellung einer Suspension (Rezept) | | | | |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
076 | 16 Gélule(s) | 12.93 | 30.40 | A | LS | Oui |
|
|